Noerr

Not specified

McKesson Corporation

Cardinal Health

AmerisourceBergen

IQVIA Holdings, Inc.

Cencora PharmaLex faces strong competition in the pharmaceutical services and consulting market. Its main competitors include large pharmaceutical distributors like McKesson, Cardinal Health, and AmerisourceBergen, which offer similar services and have significant market presence. Additionally, specialized healthcare consulting and analytics firms like IQVIA pose competition in the consulting and regulatory affairs segments. These competitors have substantial financial resources, established client relationships, and global reach, making the market highly competitive. Cencora PharmaLex will need to leverage its expertise in regulatory affairs and consulting services, as well as its recent acquisition by AmerisourceBergen, to maintain and grow its market position.

Cencora PharmaLex

Align Technology, Inc.

Medpace

Cencora PharmaLex provides pharmaceutical and healthcare consulting services, focusing on regulatory affairs, product development, and quality management.

PharmaLex is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives around the world

PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.

Learn more at http://www.pharmalex.com

PharmaLex

Unlock the future of personalized medicine with insights from Dr. Christian K Schneider in his latest article on targeted therapies!

Key takeaways include:
✅ The revolutionary impact of targeted medicines on patient outcomes.
✅  How biomarkers and companion diagnostics (CDx) connect life-saving therapies 
✅  The critical role of AI and machine learning in advancing precision medicine.
✅  Navigating regulatory pathways for successful approval and delivery.
✅  The importance of collaboration between developers, diagnostic teams, and regulators.

Explore the full article here: https://lnkd.in/dQhNng8V

#PharmaLex #TargetedMedicine #TargetedTherapies #Biomarkers #CompanionDiagnostics #RegulatoryAffairs #PharmaceuticalInnovation

What an incredible session at #JSM2024 in Portland discussing the regulatory acceptability of Bayesian methods! 

A huge shoutout to our team members Martina Fortin, Lauren Frazee, PhD, Brad Carlin and our brilliant speakers John Scott and Freda Cooner from FDA , Amy Xia from Amgen, Lauren Frazee, PhD from PharmaLex, and Ruitao Lin from MD Anderson Cancer Center.

The future of Bayesian methods in US and international regulatory science is truly promising!

Learn more about Statistics & Data Science at PharmaLex here: https://lnkd.in/gxRQJ48n

#BayesianMethods #RegulatoryScience #PharmaLex #DataScience

Automation, AI, and data analytics are transforming pharmaceutical outsourcing, bringing unprecedented agility, efficiency, and cost-effectiveness. Curious about how these innovations are shaping the future of drug development and commercialization?

Learn more in our latest blog post from Kirsten Jacobs, PhD, Chief Strategy Officer with PharmaLex: https://lnkd.in/dS-Qs_gc 

#PharmaLex #FutureofHealthcare #AI #Innovation

Stay informed of all the latest news, events, and thought leadership in the pharmaceutical, biotech and medical device industry!

Subscribe to our newsletter for exclusive industry insights about the rapidly-evolving #pharmaceutical industry ➡️ https://lnkd.in/ejiXKmbd

#Pharmalex #Newsletter

Join us tomorrow, August 6th, at 4:00 PM CET for our second Summer Shorts of our TMF Excellence Edition on the topic: "Risk-Based Quality Review: Inside Out". 

Our experts will guide you through managing and resolving conflicting directives. Learn how to navigate the complexities and find the right path for your organization.

⏰ Duration: 30 min

Secure your spot now: https://lnkd.in/dqTHKRmN

#PharmaLex #TMFExcellence #RiskBasedReview #ClinicalResearch #Webinar #SummerShorts Rob Jones

Happy to be at #JSM2024 in Portland with the other members of the Cencora-PharmaLex "dream team", Martina Fortin and Lauren Frazee, PhD! 

We're here for one more day; if you're in Portland, please stop by Booth 310 in the convention center Expo, say hello, and pick up some cool swag!

Establishes a regulatory framework for laboratory-developed tests (LDTs), modifying the definition of in vitro diagnostic products (IVDs) to include LDTs.

Proposed changes to marketing exclusivity periods and regulatory processes in the EU.

COM:PHARMALEX

Cencora PharmaLex

Analysis Not Available